<div id="readability-page-1">Goldman Sachs analysts last week noted that hedge funds in Q3 2025 rotated away from consumer discretionary stocks into health care. That increase in the pharma space was concentrated in biotech. Below is Goldman's list of those health care stocks that saw the largest net increases in popularity among hedge funds in the quarter, ranked according to...</div>

OCUL

百时美施贵宝

福泰制药

<p>高盛分析师报告称，2025 年第三季度对冲基金的投资从消费品类股票转向医疗保健股票，特别是生物技术领域。Vertex Pharmaceuticals、百时美施贵宝和 Ocular Therapeutix 是评级最高的股票，具有强劲的 Seeking Alpha 量化评级。该评级系统根据估值、增长、盈利能力和动量对股票进行评估，评级超过 3.5 被视为看涨</p>

SA Quant 对高盛的医疗保健股票进行排名，这些股票在对冲基金中的受欢迎程度增长幅度最大